President Donald Trump announced plans to impose tariffs on imported pharmaceuticals, beginning with a modest rate that could rise to as much as 250% within the next year to year and a half.
He said the move is intended to encourage domestic manufacturing in strategic sectors such as healthcare and technology, reinforcing supply chains and creating jobs at home.
Trump also warned the European Union that tariffs could increase if the bloc does not honor a pledged $600 billion in investment in the United States, characterizing the commitment as a form of assistance that must be fulfilled.